11.07.2015 Views

Mohammed T. Abou-Saleh

Mohammed T. Abou-Saleh

Mohammed T. Abou-Saleh

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

NOSOLOGY OF DEMENTIA 1898. Blennow K, Skoog I. Genetic testing for Alzheimer’s disease: howclose is reality? Curr Opin Psychiat, 1999; 12: 487–93.9. Skoog I. Blood pressure and dementia. In Hansson L, BirkenhägerWH (eds), Handbook of hypertension. Vol 18, Assessment ofHypertensive Organ Damage. Amsterdam: Elsevier Science, 1997.10. Román GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia:diagnostic criteria for research studies. Report of the NINDS–AIREN international workshop. Neurology 1993; 43: 250–60.11. Hachinski VC, Illif LD, Zihka E et al. Cerebral flow in dementia.Arch Neurol 1975; 32, 632–7.12. Bowler JV, Hachinski V. Vascular cognitive impairment: a newapproach to vascular dementia. In Baillie`re’s Clinical Neurology.London: Baillière Tindall, 1995; 357–76.13. Tatemichi TK, Desmond DW, Mayeux R et al. Dementia afterstroke: baseline frequency, risks, and clinical features in a hospitalisedcohort. Neurology 1992; 42: 1185–93.14. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia threemonths after stroke. Baseline frequency and effect of differentdefinitions of dementia in the Helsinki Stroke Aging Memory(SAM) cohort. Stroke 1997; 28: 785–92.15. Erkinjuntti T, Hachinski V. Dementia post stroke. In PhysicalMedicine and Rehabilitation: State of the Art Reviews, vol 7.Philadelphia, PA: Hanley & Belfus, 1993.16. Tatemichi TK, Sacktor N, Mayeux R. Dementia associated withcerebrovascular disease, other degenerative diseases, and metabolicdisorders. In Terry RD, Katzman R, Bick KL (eds), AlzheimerDisease. 1994; New York: Raven.17. Skoog I. Risk factors for vascular dementia. A review. Dementia1994; 5: 137–44.18. Fischer P, Gatterer G, Marterer A et al. Course characteristics in thedifferentiation of dementia of the Alzheimer type and multi-infarctdementia. Acta Psychiat Scand 1990; 81: 551–3.19. Tomlinson BE, Blessed G, Roth M. Observations on the brains ofdemented old people. J Neurol Sci 1970; 11: 205–42.20. Arriagada P, Marzloff K, Hyman B. Distribution of Alzheimer-typepathologic changes in non-demented elderly individuals matches thepattern in Alzheimer’s disease. Neurology, 1992; 42: 1681–8.21. Del Ser T, Bermejo F, Portera A et al. Vascular dementia. Aclinicopathological study. J Neurol Sci 1990; 96: 1–17.22. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinicalcriteria for Alzheimer’s disease, vascular dementia and dementia withLewy bodies. Br J Psychiat 1999; 174: 45–50.23. Lim A, Tsuang D, Kukull W et al. Clinico-neuropathologicalcorrelation of Alzheimer’s disease in a community-based case series.J Am Geriat Soc 1999; 47: 564–9.24. Snowdon DA, Greiner LH, Mortimer JA et al. Brain infarction andthe clinical expression of Alzheimer disease. The Nun Study. JAmMed Assoc 1997; 277: 813–17.25. Skoog I, Kalaria RN, Breteler MM. Vascular factors and Alzheimerdisease. Alzheimer’s Dis Assoc Disord 1999; 13(suppl 3): S106–14.26. Brun A, Englund E, Gustafson L et al. Clinical andneuropathological criteria for frontotemporal dementia. J NeurolNeurosurg Psychiat 1994; 57: 416–18.27. Neary D, Snowden JS, Gustafson L et al. Frontotemporal lobardegeneration: a consensus on clinical diagnostic criteria. Neurology,1998; 51: 1546–54.28. McKeith IG, Perry RH, Fairbairn AF et al. Operational criteria forsenile dementia of Lewy body type (SDLT). Psychol Med 1992; 22:911–22.29. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis ofAlzheimer’s disease: report of the NINCDS–ADRDA work groupunder the auspices of Department of Health and Human ServicesTask Force on Alzheimer’s disease. Neurology, 1984; 34: 939–44.Cross-national Inter-rater Reliability ofDementia DiagnosisDaniel W. O’ConnorMonash University, Melbourne, AustraliaDSM-IV 1 , ICD-10 2 and other glossaries have proved successful inpromoting a common approach to psychiatric diagnosis. In fieldtrials of DSM-III-R, for example, psychiatrists achieved concordancerates for diagnosing dementia of 0.91, where 1.0represents complete agreement 3 .It cannot be assumed, however, that similar performances willbe achieved in ‘‘real world’’ practice. Most studies of diagnosticreliability involve assessments by experienced clinicians ofcooperative, physically healthy old people who are either‘‘normal’’ controls or ‘‘pure cases’’ of dementia. In reality,cognitive function lies on a spectrum and assessment is oftencomplicated by limited education, deafness, poor vision, physicalillness, anxiety or depression.In a study of five research teams in Australia, Germany, TheNetherlands, the UK and the USA, each centre contributed 20written vignettes of elderly persons encountered in clinics orcommunity surveys 4 . No exclusions were made because ofmedical, neurological or psychiatric complications. The vignetteswere brief and highly structured. The contents included subjects’demographic details, medical and psychiatric history, abbreviatedcognitive test results and an informant’s report of cognitive,personal and social performance.When 13 researchers applied DSM-III-R criteria to the 100vignettes, within-team levels of diagnostic agreement were high,ranging from kappa 0.72 in the centre with the least joint trainingto 0.86 in the centre with most. Between-team agreement waslower but still acceptable, with kappas ranging from 0.74 to 0.83.Some elements of DSM-III-R were easier to apply consistentlythan others. Mean percentage agreement was highest for socialand occupational dysfunction (94%) and lowest for impairmentof higher cortical function (87%). Concordance was alsosignificantly higher for cognitively intact (98%) and severelyimpaired (96%) persons than for those with minimal (80%) andmild (82%) degrees of dementia.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!